Description
This naphthalene exhibits anticancer activity; in fibrosarcoma and breast cancer cells, it increases expression of STAT1 and IFN regulatory factor 1 and enhances the ability of IFNγ to inhibit cell proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This naphthalene exhibits anticancer activity; in fibrosarcoma and breast cancer cells, it increases expression of STAT1 and IFN regulatory factor 1 and enhances the ability of IFNγ to inhibit cell proliferation.
| Cas No. | 65182-56-1 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10N2O |
| Formula Wt. | 222.24 |
| IUPAC Name | 6-(1H-1,8-naphthyridin-2-ylidene)cyclohexa-2,4-dien-1-one |
| Synonym | 2-NP |
| Solubility | Ethanol (7 mg/mL), DMSO (50 mg/mL) |
| Appearance | Red Crystals |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lynch RA, Etchin J, Battle TE, et al. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells. Cancer Res. 2007 Feb 1;67(3):1254-61. PMID: 17283162.
Synthesis impurity
δ2OR antagonist.
Valsartan impurity
Mycotoxin produced by Aspergillus; actin polyme...
β1-adrenergic antagonist.
β2-adrenergic agonist.
Endogenous component of sphingolipids; PKC inhi...
Opioid neuropeptide; kyotorphin agonist.
Fatty acid synthase inhibitor.
Non-depolarizing NMJ blocker; nAChR antagonist....
Cysteine-ITC conjugate, antioxidant.
ROCK inhibitor.
Non-opioid analgesic.
Sphingosine 1-phosphate antagonist.
Protonophore; chitinase OvCHT1 inhibitor.
CDK1/2 inhibitor.
FAK inhibitor.
Found in Buxus; hERG K+ channel inhibitor.
S-adenosylmethionine nucleoside analog; methylt...
Antioxidant.